866 related articles for article (PubMed ID: 16551211)
1. Dry powder aerosol delivery systems: current and future research directions.
Chan HK
J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
[TBL] [Abstract][Full Text] [Related]
2. Development of dry powder inhalers.
Chougule MB; Padhi BK; Jinturkar KA; Misra A
Recent Pat Drug Deliv Formul; 2007; 1(1):11-21. PubMed ID: 19075871
[TBL] [Abstract][Full Text] [Related]
3. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems.
Young PM; Sung A; Traini D; Kwok P; Chiou H; Chan HK
Pharm Res; 2007 May; 24(5):963-70. PubMed ID: 17377746
[TBL] [Abstract][Full Text] [Related]
4. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
5. Dry powder inhaler formulation.
Telko MJ; Hickey AJ
Respir Care; 2005 Sep; 50(9):1209-27. PubMed ID: 16122404
[TBL] [Abstract][Full Text] [Related]
6. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
7. The role of particle properties in pharmaceutical powder inhalation formulations.
Chew NY; Chan HK
J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
[TBL] [Abstract][Full Text] [Related]
8. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
[TBL] [Abstract][Full Text] [Related]
10. The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics.
Begat P; Morton DA; Staniforth JN; Price R
Pharm Res; 2004 Oct; 21(10):1826-33. PubMed ID: 15553229
[TBL] [Abstract][Full Text] [Related]
11. Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers.
Saini D; Biris AS; Srirama PK; Mazumder MK
Pharm Dev Technol; 2007; 12(1):35-41. PubMed ID: 17484142
[TBL] [Abstract][Full Text] [Related]
12. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
Telko MJ; Kujanpää J; Hickey AJ
Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
[TBL] [Abstract][Full Text] [Related]
13. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach.
Hooton JC; Jones MD; Price R
J Pharm Sci; 2006 Jun; 95(6):1288-97. PubMed ID: 16637052
[TBL] [Abstract][Full Text] [Related]
14. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
Ali M; Mazumder MK; Martonen TB
J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
[TBL] [Abstract][Full Text] [Related]
15. A dry powder inhaler with reduced mouth-throat deposition.
Wang ZL; Grgic B; Finlay WH
J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
[TBL] [Abstract][Full Text] [Related]
16. Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols.
Kwok PC; Chan HK
Pharm Res; 2008 Feb; 25(2):277-88. PubMed ID: 17619997
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary drug delivery by powder aerosols.
Yang MY; Chan JG; Chan HK
J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
[TBL] [Abstract][Full Text] [Related]
18. Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler.
Coates MS; Chan HK; Fletcher DF; Chiou H
Pharm Res; 2007 Aug; 24(8):1450-6. PubMed ID: 17404813
[TBL] [Abstract][Full Text] [Related]
19. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
Jetzer MW; Schneider M; Morrical BD; Imanidis G
J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
